Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,026
archived clinical trials in
Epilepsy

Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Idaho
1716
mi
from 43215
Boise, ID
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Idaho
1716
mi
from 43215
Boise, ID
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Illinois
277
mi
from 43215
Chicago, IL
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Illinois
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Illinois
277
mi
from 43215
Chicago, IL
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Illinois
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Kansas
722
mi
from 43215
Manhattan, KA
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Kansas
722
mi
from 43215
Manhattan, KA
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Kentucky
154
mi
from 43215
Lexington, KY
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Kentucky
154
mi
from 43215
Lexington, KY
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Maryland
340
mi
from 43215
Baltimore, MD
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Maryland
340
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Maryland
340
mi
from 43215
Baltimore, MD
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Maryland
340
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Michigan
164
mi
from 43215
Detroit, MI
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Michigan
164
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Nevada
1940
mi
from 43215
Reno, NV
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Nevada
1940
mi
from 43215
Reno, NV
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, New Hampshire
609
mi
from 43215
Lebanon, NH
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, New Hampshire
609
mi
from 43215
Lebanon, NH
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, New Jersey
476
mi
from 43215
Hackensack, NJ
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, New Jersey
476
mi
from 43215
Hackensack, NJ
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, New York
485
mi
from 43215
Bronx, NY
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, New York
485
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, New York
481
mi
from 43215
New York, NY
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, New York
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, New York
261
mi
from 43215
Stony Brook, NY
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, New York
261
mi
from 43215
Stony Brook, NY
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, North Carolina
352
mi
from 43215
Durham, NC
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, North Carolina
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Ohio
1
mi
from 43215
Columbus, OH
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Ohio
1
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Oklahoma
849
mi
from 43215
Oklahoma City, OK
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Oklahoma
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Oregon
2026
mi
from 43215
Portland, OR
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Oregon
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Pennsylvania
416
mi
from 43215
Philadelphia, PA
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Pennsylvania
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Tennessee
332
mi
from 43215
Nashville, TN
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Tennessee
332
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Texas
904
mi
from 43215
Dallas, TX
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Texas
904
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Texas
904
mi
from 43215
Dallas, TX
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Texas
904
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Texas
937
mi
from 43215
Fort Worth, TX
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Texas
937
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Texas
1138
mi
from 43215
San Antonio, TX
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Texas
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Texas
1138
mi
from 43215
San Antonio, TX
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Texas
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Virginia
423
mi
from 43215
Norfolk, VA
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Virginia
423
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Wisconsin
393
mi
from 43215
Madison, WI
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Wisconsin
393
mi
from 43215
Madison, WI
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, California
1958
mi
from 43215
Orange, CA
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, California
1958
mi
from 43215
Orange, CA
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, North Carolina
306
mi
from 43215
Winston-Salem, NC
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, North Carolina
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Tennessee
508
mi
from 43215
Memphis, TN
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Tennessee
508
mi
from 43215
Memphis, TN
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Texas
864
mi
from 43215
Greenville, TX
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Texas
864
mi
from 43215
Greenville, TX
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
Australia, New South Wales
9456
mi
from 43215
Randwick,
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
Australia, New South Wales
9456
mi
from 43215
Randwick,
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Arizona
1639
mi
from 43215
Tucson, AZ
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Arizona
1639
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Florida
929
mi
from 43215
Loxahatchee Groves, FL
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Florida
929
mi
from 43215
Loxahatchee Groves, FL
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Minnesota
617
mi
from 43215
Saint Paul, MN
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Minnesota
617
mi
from 43215
Saint Paul, MN
Click here to add this to my saved trials
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated:  3/15/2018
United States, Missouri
394
mi
from 43215
Saint Louis, MO
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
An Open-Label Safety Study of USL261 in the Outpatient Treatment of Subjects With Seizure Clusters
Status: Enrolling
Updated: 3/15/2018
United States, Missouri
394
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated:  3/20/2018
University of Kansas Medical Center
627
mi
from 43215
Kansas City, KA
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated: 3/20/2018
University of Kansas Medical Center
627
mi
from 43215
Kansas City, KA
Click here to add this to my saved trials
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated:  3/20/2018
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated: 3/20/2018
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated:  3/20/2018
Yale University School of Medicine
537
mi
from 43215
New Haven, CT
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated: 3/20/2018
Yale University School of Medicine
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated:  3/20/2018
St. Joseph's Hospital and Medical Center
1661
mi
from 43215
Phoenix, AZ
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated: 3/20/2018
St. Joseph's Hospital and Medical Center
1661
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated:  3/20/2018
Mount Sinai-West
532
mi
from 43215
New York, NY
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated: 3/20/2018
Mount Sinai-West
532
mi
from 43215
New York, NY
Click here to add this to my saved trials
In Vivo Imaging of Therapeutic Electric Current Flow
In Vivo Imaging of Therapeutic Electric Current Flow
Status: Enrolling
Updated:  4/4/2018
University of Florida
714
mi
from 43215
Gainesville, FL
In Vivo Imaging of Therapeutic Electric Current Flow
In Vivo Imaging of Therapeutic Electric Current Flow
Status: Enrolling
Updated: 4/4/2018
University of Florida
714
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
Stress Management Intervention for Living With Epilepsy (SMILE)
Pre-emptive Treatment in Epilepsy Using Electronic Diaries: Towards a New Frontier in Epilepsy Therapy
Status: Enrolling
Updated:  4/17/2018
Montefiore Medical Center
484
mi
from 43215
Bronx, NY
Stress Management Intervention for Living With Epilepsy (SMILE)
Pre-emptive Treatment in Epilepsy Using Electronic Diaries: Towards a New Frontier in Epilepsy Therapy
Status: Enrolling
Updated: 4/17/2018
Montefiore Medical Center
484
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
Stress Management Intervention for Living With Epilepsy (SMILE)
Pre-emptive Treatment in Epilepsy Using Electronic Diaries: Towards a New Frontier in Epilepsy Therapy
Status: Enrolling
Updated:  4/17/2018
University of Cincinnati
98
mi
from 43215
Cincinnati, OH
Stress Management Intervention for Living With Epilepsy (SMILE)
Pre-emptive Treatment in Epilepsy Using Electronic Diaries: Towards a New Frontier in Epilepsy Therapy
Status: Enrolling
Updated: 4/17/2018
University of Cincinnati
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Stress Management Intervention for Living With Epilepsy (SMILE)
Pre-emptive Treatment in Epilepsy Using Electronic Diaries: Towards a New Frontier in Epilepsy Therapy
Status: Enrolling
Updated:  4/17/2018
University of California at San Francisco
2109
mi
from 43215
San Francisco, CA
Stress Management Intervention for Living With Epilepsy (SMILE)
Pre-emptive Treatment in Epilepsy Using Electronic Diaries: Towards a New Frontier in Epilepsy Therapy
Status: Enrolling
Updated: 4/17/2018
University of California at San Francisco
2109
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Austin Epilepsy Care Center
1058
mi
from 43215
Austin, TX
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Austin Epilepsy Care Center
1058
mi
from 43215
Austin, TX
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Bradenton Research Center
862
mi
from 43215
Bradenton, FL
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Bradenton Research Center
862
mi
from 43215
Bradenton, FL
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Clinical Trials, Inc.
624
mi
from 43215
Little Rock, AR
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Clinical Trials, Inc.
624
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Consultants in Epilepsy and Neurology, PLLC
1716
mi
from 43215
Boise, ID
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Consultants in Epilepsy and Neurology, PLLC
1716
mi
from 43215
Boise, ID
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials